Silverback Therapeutics

Silverback Therapeutics

Silverback Therapeutics

Silverback Therapeutics is charting a new path for treating a range of severe diseases.
Founded
2016
Raised
$126M
Follow us
Alexa global traffic share
20 Sep 2018
$37,500,000
Venture capital (Series A)

Silverback Therapeutics Extends Series A to $47.5M

FinSMEs
+1
14 Feb 2017
$10,000,000
Venture capital

Neurosurgery professor raises cash for stealthy biotech startup Silverback Therapeutics

GeekWire
+1